LNSR LENSAR, Inc.

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.

$6.41  -0.10 (-1.54%)
As of 07/01/2022 16:30:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  USA
IPO date:  10/02/2020
Outstanding shares:  10,984,813
Average volume:  24,676
Market cap:   $71,511,133
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -3.34
PB ratio:   1.41
PS ratio:   1.95
Return on equity:   -42.35%
Net income %:   -57.39%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy